Clinical trials

  • Clinical trial in Geographic atrophy (dry age-related macular degeneration)
  • BI 690517 for Chronic kidney disease
  • FARICIMAB for Neovascular age-related macular degeneration
  • Vutrisiran for Transthyretin amyloidosis with cardiomyopathy (ATTR amyloidosis with cardiomyopathy)
  • Tezepelumab for Severe asthma | Chronic rhinosinusitis with nasal polyps
  • CK-301 for Cutaneous squamous cell carcinoma (unresectable or metastatic)
  • Methotrexate for Metastatic osteosarcoma
  • Pembrolizumab for Glioblastoma multiforme
  • HYDROCORTISONE for Pancreatic resection
  • OZEKIBART for Conventional chondrosarcoma
  • LENIOLISIB PHOSPHATE for Common variable immunodeficiency
  • MZE829 for APOL1-mediated kidney disease | Proteinuric chronic kidney disease